Accordingly, we report herewith the results of a comparative analysis of clinical and laboratory features, treatment and outcomes in TMA patients requiring PEX with and without severe ADAMTS13 deficiency. The gene discussed is ADAMTS13; the disease is hyperinsulinemic hypoglycemia, familial, 4.